Richard A. Heyman

Insider Reports History

Location
Del Mar, CA
Signature
/s/ Ben Hohl, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard A. Heyman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Oric Pharmaceuticals, Inc. Director Common Stock 213,072 $2,557,844 $12.00 16 Jan 2026 Indirect
Enliven Therapeutics, Inc. Director Common Stock 123,673 $1,904,564 $15.40 20 Jan 2026 Direct
Enliven Therapeutics, Inc. Director Common Stock 23,877 $643,628 $26.96 20 Jan 2026 Indirect
Oric Pharmaceuticals, Inc. Director Common Stock 41,800 $501,792 $12.00 16 Jan 2026 Direct
RayzeBio, Inc. Director Common Stock 0 $0 $62.50 26 Feb 2024 Direct
Oric Pharmaceuticals, Inc. Director Stock Option (right to buy) 40,000 02 Jan 2026 Direct
PMV Pharmaceuticals, Inc. Director Stock Option (right to buy) 33,500 05 Jun 2025 Direct
Enliven Therapeutics, Inc. Director Stock Option (right to buy) 23,014 06 Feb 2025 Direct
Gritstone bio, Inc. Director Stock Option (Right to Buy) 19,000 17 Jun 2022 Direct
Metacrine, Inc. Director Stock Option (right to buy) 16,500 18 May 2022 Direct
YUMANITY THERAPEUTICS, INC. Director Stock Option (Right to Buy) 14,800 02 Jun 2021 Direct

Insider Reports Filed by Richard A. Heyman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELVN Enliven Therapeutics, Inc. 20 Jan 2026 2 -$32,902 4 Director 22 Jan 2026, 17:33
ORIC Oric Pharmaceuticals, Inc. 16 Jan 2026 2 -$80,431 4 Director 20 Jan 2026, 19:19
ELVN Enliven Therapeutics, Inc. 08 Jan 2026 3 -$348,281 4 Director 12 Jan 2026, 17:11
ORIC Oric Pharmaceuticals, Inc. 02 Jan 2026 1 $0 4 Director 06 Jan 2026, 16:46
ORIC Oric Pharmaceuticals, Inc. 03 Oct 2025 5 +$55,591 4 Director 03 Oct 2025, 19:18
PMVP PMV Pharmaceuticals, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:26
ELVN Enliven Therapeutics, Inc. 06 Feb 2025 1 $0 4 Director 10 Feb 2025, 17:38
ORIC Oric Pharmaceuticals, Inc. 02 Jan 2025 1 $0 4 Director 06 Jan 2025, 16:44
ELVN Enliven Therapeutics, Inc. 18 Oct 2024 2 -$47,104 4 Director 22 Oct 2024, 16:18
ELVN Enliven Therapeutics, Inc. 15 Oct 2024 1 -$35,143 4 Director 17 Oct 2024, 17:06
ELVN Enliven Therapeutics, Inc. 04 Oct 2024 1 -$77,704 4 Director 08 Oct 2024, 18:54
ELVN Enliven Therapeutics, Inc. 01 Oct 2024 1 -$14,264 4 Director 03 Oct 2024, 18:43
ELVN Enliven Therapeutics, Inc. 16 Sep 2024 1 -$28,458 4 Director 18 Sep 2024, 16:17
ELVN Enliven Therapeutics, Inc. 15 Aug 2024 2 -$29,526 4 Director 19 Aug 2024, 19:49
ELVN Enliven Therapeutics, Inc. 31 Jul 2024 2 -$64,663 4 Director 02 Aug 2024, 19:22
ELVN Enliven Therapeutics, Inc. 15 Jul 2024 1 -$31,497 4 Director 17 Jul 2024, 19:25
ELVN Enliven Therapeutics, Inc. 17 Jun 2024 1 -$27,278 4 Director 20 Jun 2024, 19:20
ORIC Oric Pharmaceuticals, Inc. 12 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:21
PMVP PMV Pharmaceuticals, Inc. 06 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:22
ELVN Enliven Therapeutics, Inc. 16 May 2024 1 -$30,150 4 Director 20 May 2024, 19:46
ELVN Enliven Therapeutics, Inc. 11 Apr 2024 4 -$167,888 4 Director 15 Apr 2024, 19:03
ELVN Enliven Therapeutics, Inc. 19 Mar 2024 1 -$18,419 4 Director 21 Mar 2024, 18:41
/report/000141588924005525-heyman-richard-a-2024-02-26 RayzeBio, Inc. 26 Feb 2024 1 -$22,965,375 4 Director 27 Feb 2024, 16:59
ELVN Enliven Therapeutics, Inc. 15 Feb 2024 1 -$22,117 4 Director 20 Feb 2024, 19:41
ELVN Enliven Therapeutics, Inc. 13 Feb 2024 1 $0 4/A Director 20 Feb 2024, 19:32
ELVN Enliven Therapeutics, Inc. 13 Feb 2024 1 $0 4 Director 15 Feb 2024, 20:52
ELVN Enliven Therapeutics, Inc. 30 Jan 2024 1 -$20,840 4 Director 01 Feb 2024, 20:10
ELVN Enliven Therapeutics, Inc. 21 Dec 2023 4 -$2,808 4 Director 26 Dec 2023, 19:29
ELVN Enliven Therapeutics, Inc. 19 Dec 2023 3 -$55,727 4 Director 21 Dec 2023, 16:28
/report/000120919123049503-heyman-richard-a-2023-09-14 RayzeBio, Inc. 14 Sep 2023 0 $0 3 Director 14 Sep 2023, 20:26
ORIC Oric Pharmaceuticals, Inc. 14 Jun 2023 1 $0 4 Director 15 Jun 2023, 16:54
PMVP PMV Pharmaceuticals, Inc. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 17:39
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 1 $0 4 Director 06 Apr 2023, 20:19
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 4 $0 4 Director 27 Feb 2023, 20:54
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 0 $0 3 Director 27 Feb 2023, 20:53
/report/000156761922013257-heyman-richard-a-2022-06-17 Gritstone bio, Inc. 17 Jun 2022 1 $0 4 Director 22 Jun 2022, 17:32
ORIC Oric Pharmaceuticals, Inc. 17 Jun 2022 1 $0 4 Director 17 Jun 2022, 20:22
PMVP PMV Pharmaceuticals, Inc. 02 Jun 2022 1 $0 4 Director 06 Jun 2022, 17:41
/report/000120919122048881-heyman-richard-a-2022-05-18 Metacrine, Inc. 18 May 2022 1 $0 4 Director 06 Sep 2022, 19:23
ORIC Oric Pharmaceuticals, Inc. 14 Sep 2021 2 -$34,760 4 Director 16 Sep 2021, 18:19
ORIC Oric Pharmaceuticals, Inc. 10 Sep 2021 2 -$27,056 4 Director 14 Sep 2021, 16:03
ORIC Oric Pharmaceuticals, Inc. 07 Sep 2021 1 -$27,272 4 Director 09 Sep 2021, 16:36
/report/000156761921020858-heyman-richard-a-2021-06-18 Gritstone bio, Inc. 18 Jun 2021 1 $0 4 Director 19 Nov 2021, 15:57
ORIC Oric Pharmaceuticals, Inc. 16 Jun 2021 1 $0 4 Director 17 Jun 2021, 19:46
PMVP PMV Pharmaceuticals, Inc. 02 Jun 2021 1 $0 4 Director 09 Jun 2021, 17:30
KANT YUMANITY THERAPEUTICS, INC. 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 16:05
PMVP PMV Pharmaceuticals, Inc. 01 Jun 2021 15 +$832,318 4 Director 02 Jun 2021, 16:11
/report/000120919121035784-heyman-richard-a-2021-05-24 Metacrine, Inc. 24 May 2021 1 $0 4 Director 25 May 2021, 19:01
ORIC Oric Pharmaceuticals, Inc. 20 May 2021 3 -$35,208 4 Director 24 May 2021, 19:30
ORIC Oric Pharmaceuticals, Inc. 14 May 2021 3 -$148,582 4 Director 18 May 2021, 20:22
PMVP PMV Pharmaceuticals, Inc. 12 May 2021 1 $0 4 Director 23 Jul 2021, 16:07
ORIC Oric Pharmaceuticals, Inc. 11 May 2021 1 -$2,511 4 Director 13 May 2021, 20:00